[1]
R., D.S., R., R. and M. R., R.P.R. 2017. Toxicity profile of thal-dex regime in patients with multiple myeloma. International Journal of Basic & Clinical Pharmacology. 6, 5 (Apr. 2017), 1073–1077. DOI:https://doi.org/10.18203/2319-2003.ijbcp20171505.